baber/WOPTO huggingface dataset:
Patent NZ-518578-A (NZ)
Title: Fish bag for storage and transport of living fish having, at ends, rings and second netting with purse lines
Inventor: JENSSEN INGE HENNING
IPC: A01K74/00
Filed: 2000-10-04
Abstract: A fish bag (1) is disclosed comprising at each end bag rings (3) and a second netting (4) with purse lines (5, 6). A preferred embodiment discloses a towing line (not shown) and one or more braces (not shown) and locking rings (not shown) to connect several fish bags (1) into larger units.
Patent NZ-518803-A (NZ)
Title: Condensed azepines as vasopressin agonists
Inventor: ASHWORTH DOREEN MARY
IPC: C07D413/12
Filed: 2001-01-04
Abstract: The disclosed provides compounds according to  general formula  (1)  wherein A is a bicyclic or  tricyclic  azepine derivative,  V1 and V2 are both H, OMe or F, or  one  of  V2 and  V2 is Br, Cl, F, OH, OMe, OBn, OPh, O-acyl, Br, Cl,  F, N3,  NH2, NHBn or NH-acyl and the other is H, or V1  and  V2 together  are =O, -S(CH2)pS- or -O(CH2)pO-; W1 is  either  O or  S; X1 and X2 are both H, or together are =O or =S; Y  is OR5  or  NR6R7; R1, R2, R3 and R4 are independently selected from  H,  lower alkyl, lower alkyloxy, F, Cl and Br;  R5  is selected   from   H  and  lower  alkyl;  R6   and   R7   are independently selected from H and lower alkyl,  or  together are  -(CH2)n-; n=3, 4, 5, 6; and p is 2 or 3. The  compounds are  agonists at the vasopressin V2 receptor and are  useful as  antidiuretics  and procoagulants. The disclosed  further comprises  pharmaceutical compositions  incorporating  these vasopressin  agonists, which compositions  are  particularly useful  in  the  treatment  of central  diabetes  insipidus, nocturnal enuresis and nocturia.
Patent NZ-526426-A (NZ)
Title: Ground assessment device, typically for racetrack, with compression and shear sensors
Inventor: BRIGHTON JAMES LAURENT
IPC: G01N3/08
Filed: 2001-11-26
Abstract: For assessing ground quality, such as the 'going' of a racetrack a handheld device has a shaft (10), a plate (16) mounted to its bottom end, and a sensor body (27) also mounted to the bottom of the shaft (10), independently of the plate (16). A tine tip (20) projects below the body. The body has compression sensors (36) and shear sensors (34). The user pushes down on the shaft (10). The tine (20) penetrates the ground until the plate (16) abuts the surface. Continued pushing leads to a compression reading. The user then pushes the top of the shaft so that it tilts, pivoting about an edge of the plate. Shear forces are sensed by the shear sensors (34). The compression and shear data pass to a data processor (26) which computes a single value indicative of 'going'.
Patent NZ-530305-A (NZ)
Title: Contents delivery method, scenario data, recording medium, and scenario data creation method
Inventor: SARUHASHI NOZOMU
IPC: H04N21/8543
Filed: 2002-06-24
Abstract: A contents delivery method for delivering multimedia contents stored in advance to a plurality of user terminals by using a communication line comprises: storing the material contents that are material of contents to be delivered; storing the scenario data for defining order of replay of the material contents along a time axis; accepting a delivery request from one of the user terminals; fetching the stored scenario data specified by the accepted delivery request; delivering the fetched scenario data to each of the user terminals; fetching material contents specified by the fetched scenario data; delivering the fetched material contents to each of the user terminals; wherein each of the user terminals replays the delivered material contents based on the delivered scenario data.
Patent NZ-530339-A (NZ)
Title: Method for producing wood fibre pellets
Inventor: WARNES JEREMY MARTIN
Filed: 2004-06-23
Abstract: A process for producing pellets or granules comprising fibres of a lignocellulousic material, for use as a feedstock in plastics manufacture, conveying in a dry or wet air stream and applying to the fibres a liquid formulation comprising one or more polymers, monomers, or oligomers, forming the fibres into a solid product, and breaking down the solid product to produce said pellets or granules. Typically the conduit conveys the fibres in a plant for manufacture of fibre board.
Patent NZ-535417-A (NZ)
Title: Plastic barrier closure and method of fabrication
Inventor: SCHENCK TIMOTHY T
IPC: B65D41/04
Filed: 2003-04-10
Abstract: A plastic barrier closure (or cap) for bottles and the like that has (1) a body having a top wall (2), a side wall (3), a securing means and a seal (4) that has at least one concentric sealing member extending from the top wall, and a barrier (5) incorporated into the top wall. The barrier layer may be incorporated into the top wall by depositing a melted mass of barrier polymer in the pre-molded cap body and then moulding it into place by mechanical means or forming a barrier layer from the barrier polymer and inserting it into a pre-molded cap body.
Patent NZ-536300-A (NZ)
Title: Repetition coded compression for highly correlated image data
Inventor: THIAGARAJAN ARVIND
IPC: H04N19/94
Filed: 2003-03-07
Abstract: To increase the compressibility of image data of an image, each pixel element of the data is compared with a previous element, and if the elements are equal a first value is recorded and if the elements are not equal a second value is recorded. The values are stored as a repetition coded compression bit plane 24, which when combined with corresponding stored repetition coded compression data values 22, permits original pixel data values to be reconstructed.
Patent NZ-538342-A (NZ)
Title: Estrogen replacement regimen
Inventor: CASPER ROBERT
IPC: A61K31/57
Filed: 2003-08-28
Abstract: Disclosed is a pharmaceutical preparation, for administration to a female in need of estrogen replacement, comprising a plurality of doses arranged in alternating standard dose estrogen phases and ultra low dose estrogen phases, each phase consisting of from about 1 to about 4 consecutive daily unit doses or an equivalent thereof, wherein the daily unit doses of the standard dose estrogen phases contain an amount of a substance exhibiting estrogenic activity equivalent to from at or about 0.5 mg to at or about 5.0 mg of estradiol, and the daily unit doses of the ultra-low dose estrogen phases contain an amount of a substance exhibiting estrogenic activity equivalent to from at or about 0.005 mg to at or about 0.5 mg of estradiol. The standard dose estrogen phase may contain an amount of a substance exhibiting progestogenic activity equivalent to from 0 mg to at or about 300 mg of micronized progesterone and the ultra-low dose estrogen phase may contain an amount of a substance exhibiting progestogenic activity equivalent to from at or about 50 mg to at or about 300 mg of micronized progesterone. The amount of the substance exhibiting progestogenic activity may be alternately increased in the ultra-low dose estrogen phases to provide daily unit doses exhibiting dominant activity and decreased in the standard dose estrogen phases to provide daily unit doses exhibiting lower progestin activity.
Patent NZ-552767-A (NZ)
Title: Resource access filtering system and method
Inventor: JONES KEVIN
IPC: H04L29/08
Filed: 2005-07-28
Abstract: A resource access filtering system comprises a computer (33) and a client (32) on a device. The client establishes a remote connection to the computer and further comprises a module that gathers information about a request to access a resource (38) by the device and a module that communicates the gathered information to the computer. The computer further comprises a module that categorizes the resource access of the device based on the gathered information and a module that communicates a resource access decision to the client in real-time so that the client controls the access to the resource by the device based on the resource access decision of the computer. The client is further configured to communicate a capability mask associated with the device to the computer. The capability mask containing information about the filtering capabilities of the device and the computer is further configured to generate the resource access decision based on the capability mask.
Patent NZ-576272-A (NZ)
Title: Modulators of neuronal regeneration
Inventor: ATWAL JASVINDER
IPC: G01N33/68
Filed: 2007-11-09
Abstract: Disclosed is a method for identifying a PirB/LILRB antagonist comprising contacting a candidate agent with a complex comprising PirB/LILRB and myelin or a myelin-associated protein, or a functional fragment thereof, and detecting the ability of said candidate agent to inhibit the interaction between PirB/LILRB and said myelin or myelin-associated protein, or fragment thereof, wherein the candidate agent is identified as an antagonist if the interaction is inhibited.
Patent NZ-583435-A (NZ)
Title: A feeder cell-free culture medium and system
Inventor: UPTON ZEE
IPC: C12N5/0735
Filed: 2008-09-03
Abstract: Disclosed is a cell culture medium comprising a synthetic chimeric protein comprising an insulin-like growth factor (IGF) amino acid sequence and a vitronectin (VN) amino acid sequence and one or more isolated feeder cell-replacement factors selected from the group consisting of human growth hormone (hGH), bone morphogenic protein 15(BMP-I5), growth differentiation factor 9 (GDF-9), megakaryocyte colony stimulating factor, secreted frizzled-related protein 2, Wnt-2b, Wnt-I2, growth inhibitory factor, fetuin, human serum albumin (HSA), hepatocyte growth factor (HGF), transforming growth factor-a (TGF-a), TGF-p, nerve growth factor, platelet derived growth factor-B (PDGF-P), PC-derived growth factor (progranulin), interleukin (IL)-I, IL-2, IL-4, IL-6, IL-8, IL-IO, IL-13 and Activin-A. The culture medium has an absence of serum or a substantially reduced amount of serum which in the absence of an IGF would not support cell growth.
Patent NZ-587161-A (NZ)
Title: Automated system and and method for monitoring chromatography column performance by calculating performance parameters based on noise reduced process values
Inventor: CUNNIEN PAUL
IPC: G06F19/00
Filed: 2009-01-23
Abstract: A system and method for monitoring chromatography column performance is disclosed. The method includes the steps of: (1) Generating a plurality of process values with a detector during a chromatography step transition between a first mobile phase liquid and a second mobile phase liquid. (2) Transforming the plurality of process values to form a plurality of transformed process values. The transforming step suppresses noise present in the plurality of process values. (3) Calculating performance parameters based on the plurality of transformed process values. (4) Displaying the performance parameters calculated in (3) during movement of the second mobile phase liquid through the chromatography column. (5) Making a determination, based on the performance parameters displayed in (4),regarding the quality of the chromatography column packing.
Patent NZ-587165-A (NZ)
Title: Ampk modulators
Inventor: BIRNBERG NEAL C
IPC: A01N31/04
Filed: 2009-02-04
Abstract: Disclosed are compounds useful as AMPK modulators represented by formula I or II, wherein the substituents are as described within the specification. Examples of the disclosed compounds include: 5-(2,6-Dihydroxybiphenyl)-1H-indole-3-carbonitrile; and 5-(6-(2-Hydroxyphenyl)pyridazin-3-yl)-1H-indole-3-carbaldehyde. Further disclosed is a pharmaceutical composition comprising a therapeutically effective amount of a compound of formula I or II, and the use of a compound of formula I or II in the manufacture of a medicament for regulating AMPK, and for the treatment of diabetes, obesity and cancer.
Patent NZ-590351-A (NZ)
Title: HA1 domain totally or partially free of N-linked glycosylation operatively linked to a regulatory region
Inventor: COUTURE MANON
IPC: A01H5/00
Filed: 2009-07-15
Abstract: Provided is a nucleic acid comprising a nucleotide sequence encoding an influenza virus hemagglutinin (HA) HA 1 domain, wherein said HA 1 domain is modified to be totally or partially free of N-linked glycosylation sites, when compared to an original native HA sequence and operatively linked to a regulatory region active in a plant. Further provided are transgenic plants comprising the sequence and producing influenza virus like particles (VLPs) in a plant and use of the VLPs for inducing immunity to influenza.
Patent NZ-594764-A (NZ)
Title: Open development system for access service providers
Inventor: RALEIGH GREGORY G
IPC: H04W4/24
Filed: 2010-01-18
Abstract: A system for securely providing information to, and adapted for being used together with, an end-user device adapted for obtaining the information from the system is disclosed. The system comprises a communications interface for enabling a service control server link element in the system to communicate with a service control device link agent on an end-user device over a secure service control link on a wireless access network, the secure service control link established by executing an authorization procedure and secured by an encryption protocol and providing for control-plane communications between the system and the end-user device, the encryption protocol using an encryption key shared by the service control device link agent and the service control server link element; and one or more network elements configured to: provide information associated with one or more service-control options to the service control device link agent over the secure service control link, each of the one or more service-control options corresponding to an access-network control policy configured to govern a particular service activity of a plurality of service activities available to the end-user device, obtain a user preference from the service control device link agent over the secure service control link, the user preference indicating a particular option of the one or more service-control options, and assist in provisioning one or more network traffic-control elements to enforce a particular access-network control policy corresponding to the particular option.
Patent NZ-598437-A (NZ)
Title: Nutritional composition for lactating women
Inventor: GIORDANO THIERRY
IPC: A23L33/155
Filed: 2010-07-26
Abstract: NZ 598437 Disclosed is a nutritional composition comprising: a protein fraction; a glucid fraction; a lipid fraction comprising at least one fatty acid in the omega-3 group; at least one mineral element; at least one vitamin; and a combination of plant extracts, the combination being chosen from: an extract of barley malt plant, fenugreek and anise; or an extract of barley malt plant and fenugreek; or an extract of barley malt plant and anise; or an extract of fenugreek and anise. Also disclosed is the use of said composition for preparing a product intended to stimulate and/or initiate lactation and/or to stimulate suction during breast-feeding in a mammal.
Patent NZ-599504-A (NZ)
Title: Process for the purification of recombinant human erythropoietin (epo), epo thus purified and pharmaceutical compositions comprising same
Inventor: HINDERER WALTER
IPC: C07K1/16
Filed: 2010-09-23
Abstract: Disclosed is a method of purifying glycosylated erythropoietin (EPO) isoforms from a complex protein mixture, wherein the method comprises an anion exchange chromatography step and a cation exchange chromatography step, which are separated by a reverse phase (RP) chromatography step.
Patent NZ-604021-A (NZ)
Title: Modular guy anchor
Inventor: YOU HANMING
IPC: E02D5/80
Filed: 2011-04-20
Abstract: A modular guy anchor (200) includes an anchor head (210) and an anchor shaft (212). The anchor head (210) includes a tubular region for receiving the anchor shaft (212). The anchor shaft (212) has one end that extends into or through the tubular region and is retained therein. The anchor shaft (212) is preferably galvanized steel coated over at least a portion of its length with a corrosion-resistant material. The corrosion-resistant material is preferably applied over any portion of the anchor shaft (212) that is exposed to soil during normal use. The modularity of the guy anchor (200) facilitates stocking, shipping, and installation, while the corrosion resistance of the anchor shaft (212) promotes longevity.
Patent NZ-614445-A (NZ)
Title: Software application delivery and launching system
Inventor: URBACH JULIAN MICHAEL
IPC: G06F15/16
Filed: 2012-02-22
Abstract: Disclosed is a method for software application delivery and launching. The method comprises allocating a first virtual memory in a first computing device (330). The first computing device (330) receives executable code of a first software and writes executable code of the first software directly into the first virtual memory. The first computing device (330) executes the code of the first software directly from the first virtual memory. The first computing device (330) downloads executable code of a second software as facilitated by the executable code of the first software, the second software is disparate from the first software. The first computing device (330) executes the executable code of the second software.
Patent NZ-614995-A (NZ)
Title: Methods for the preparation of biologically active compounds in nanoparticulate form
Inventor: MEISER FELIX
IPC: A61P29/00
Filed: 2007-06-29
Abstract: Disclosed is a method for producing a composition comprising nanoparticles of a therapeutically active compound, comprising the step of: dry milling a solid therapeutically active compound and a millable grinding compound in a mill comprising a plurality of milling bodies, for a time period sufficient to produce a solid dispersion comprising nanoparticles of the therapeutically active compound dispersed in an at least partially milled grinding compound. Also disclosed is a composition comprising the nanoparticle prepared by the method.
Patent NZ-619169-A (NZ)
Title: Method and apparatus for dampening waves in a wave pool
Inventor: BASTENHOF DIRK
IPC: E04H4/00
Filed: 2009-11-25
Abstract: 619169 A method and apparatus for dampening waves in a wave pool (1) is disclosed. The wave pool has two portions, a first wave forming portion (9) with an inclined section (13) that causes the waves to begin breaking, and a second wave dampening portion (15) with a relatively deep solid chamber floor. The second portion (15) has a raised perforated floor (20) above it for dampening the waves after they begin to break. The perforated floor (20) has a porosity of less than 0.5 to dissipate wave energy which reduces wave reflections and rip currents that can interfere with the next oncoming waves. The wave pool (1) can thereby maintain quality surfing waves at high frequencies without increasing the pool size.
Patent NZ-620405-A (NZ)
Title: Shop assembled vertical serpentine flow molten salt solar receiver
Inventor: WASYLUK DAVID T
IPC: F24S10/70
Filed: 2012-07-27
Abstract: A solar receiver is disclosed. The solar receiver is modular, has multiple tube panels in a rectangular/square/polygonal/circular configuration, and is designed for use with molten salt or another heat transfer fluid. The heat transfer fluid flows in a vertical serpentine path (705) through the sides (facets) of the solar receiver. Inlet headers (716) in the facet being laterally separated from each other and outlet headers (714) in the facet are laterally separated from each other. The multiple facets (712) being arranged on an exterior of a support structure to form a NE flow quadrant, a NW flow quadrant, a SE flow quadrant, and a SW flow quadrant that are each defined by a single facet. The tube panels in each facet being oriented to locate the headers in an upper plane and a lower plane. The headers in each plane are laterally separated from each other, and the facets are fluidly connected so as to form two independent flow paths. One flow path including only the NE flow quadrant and the SW flow quadrant, and the other flow path including only the NW flow quadrant and the SE flow quadrant. The solar receiver can be shop assembled and can be used with a support tower to form a solar power system.
Patent NZ-620879-A (NZ)
Title: A novel formulation of indomethacin
Inventor: MEISER FELIX
IPC: A61K31/405
Filed: 2010-04-23
Abstract: Disclosed are unit doses of indomethacin containing 20 mg or 40 mg of indomethacin wherein the unit dose when tested in vitro by USP Apparatus I (Basket) method of U.S. Pharmacopoeia at 100 rpm at 37 °C in 900 ml of 100 mM citric acid buffer (pH 5.5 ± 0.05) has a dissolution rate of indomethacin such that at least 83% for the 20 mg unit dose or 66% for the 40 mg unit dose, by weight, is released by 75 minutes. wherein the D90 of the indomethacin, on a volume average basis, is selected from the group consisting of: less than 3000 nm, less than 2000 nm, less than 1900 nm, less than 1800 nm, and less than 1700 nm
Patent NZ-625958-A (NZ)
Title: Automated demand response energy management system
Inventor: ROMBOUTS JAN-WILLEM
IPC: H02J3/14
Filed: 2012-12-12
Abstract: Power flexibility of energy loads is maximized using a value function and outputting optimal control parameters per load. Loads are aggregated into a virtual load by maximizing a global value function including value functions for each load. The solution provides: a percentage of energy assigned to each load, a time-varying power level within a time interval for each load, and control parameters and values. An economic term of the global value function represents the value of the flexibility to different players. A user interface includes for each time interval upper and lower bounds representing maximum power that may be reduced to the virtual load and maximum power that may be consumed by the virtual load. An energy trader modifies an energy level in a time interval relative to the reference curve for the virtual load. Energy compensation for other intervals and recalculation of upper and lower boundaries occurs and is displayed. The energy schedule for the virtual load is distributed to the actual loads using the dispatch function.
Patent NZ-629569-A (NZ)
Title: Hornless livestock
Inventor: CARLSON DANIEL
IPC: C12N15/85
Filed: 2014-01-14
Abstract: Disclosed is a genetically modified livestock animal comprising a genomic modification from a horned allele to a polled allele. Also disclosed is an in vitro cell comprising a genomic modification to a horned allele of the cell.
Patent NZ-709747-A (NZ)
Title: Formulation comprising benzothiazolone compound
Inventor: TUFILLI NICOLA
IPC: A61P21/00
Filed: 2014-02-26
Abstract: Disclosed is a pharmaceutical composition in solid oral dosage form comprising 0.01 to 15% (w/w) (R)-7-(2-(1-(4-butoxyphenyl)-2-methylpropan-2-ylamino)-1-hydroxyethyl)-5- hydroxybenzo[d]thiazol-2(3H)-one acetate salt. The compound is a selective beta-2 agonist, and shows a lower affinity for the serotonin receptor (5HT2C) and lower functional potency in 5HT2c expressing cells than its racemate or its corresponding enantiomer, indicating that it does not affect locomotor activity and food intake which may cause body weight reduction, potentially counteracting beta-2 agonist-induced skeletal muscle hypertrophy.
Patent NZ-711766-A (NZ)
Title: Compositions and methods for immunotherapy
Inventor: BRENTJENS RENIER
IPC: C12N5/10
Filed: 2014-02-26
Abstract: The present invention provides for methods and compositions for enhancing the immune response toward cancers and pathogens. It relates to immunoresponsive cells bearing antigen receptors, which can be chimeric antigen receptors (CARs), which express introduced ligands for immunomodulatory molecules. In particular embodiments, engineered immunoresponsive cells are antigen-directed and resist immunosuppression and/or have enhanced immune-activating properties.